Position
Chief Financial Officer
Company
Biodexa Pharmaceuticals
CardiffBiotechnologyHealthcarePharmaceuticalBiopharmaDescription
Biodexa Pharmaceuticals PLC is pleased to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary. This appointment is effective immediately and follows Ms. Sharp's extensive contributions to the company since joining as Group Financial Controller in 2019.
Quick answer
Biodexa Pharmaceuticals Appoints Fiona Sharp as Chief Financial Officer (January 5, 2026). Biodexa Pharmaceuticals is based in Cardiff, Wales, United Kingdom.
- Who is the new Chief Financial Officer at Biodexa Pharmaceuticals?
- Biodexa Pharmaceuticals named Fiona Sharp Chief Financial Officer, announced January 5, 2026.
- What did Biodexa Pharmaceuticals announce on January 5, 2026?
- Biodexa Pharmaceuticals PLC is pleased to announce the promotion of Fiona Sharp to Chief Financial Officer and Company Secretary. This appointment is effective immediately and follows Ms. Sharp's extensive contributions to the company since joining as Group Financial Controller in 2019.
- What does Biodexa Pharmaceuticals do?
- Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs.
- Where is Biodexa Pharmaceuticals based?
- Biodexa Pharmaceuticals is based in Cardiff, Wales, United Kingdom.
- Which similar companies made leadership changes around the same time?
- Aquestive Therapeutics, Inc. (February 18, 2026), Mezzion Pharma (January 6, 2026), AstraZeneca Plc (January 8, 2026) and Centessa Pharmaceuticals plc (December 12, 2025) also announced leadership changes within 45 days of Biodexa Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aquestive Therapeutics Appoints Dr. Matthew Greenhawt as Chief Medical Officer (February 18, 2026)
- Mezzion Pharmaceuticals Appoints Ridwan Shabsigh as President and COO (January 6, 2026)
- AstraZeneca Appoints Rick R. Suarez as Senior Vice President and US President (January 8, 2026)
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
- GridAI Technologies Corp. Appoints Marshall Chapin as Chief Executive Officer (December 4, 2025)
- Jubilant Pharmova Appoints Daniel J. O’Connor as Chief Executive Officer (December 2, 2025)
Who to call at Biodexa Pharmaceuticals, and when
A new leader at Biodexa Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Biodexa Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biodexa Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biodexa Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biodexa Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biodexa Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.